Boston leaders outline vision to be center for innovation and manufacturing of next-generation medicines

I have a long-time friend who is fond of saying: “If you are going to be a bear, be a grizzly.” Well, that saying certainly applies with this idea about leveraging your assets for something big.

A group of academic, biotech, biopharma, and healthcare leaders have announced plans for a new center for innovation and manufacturing of next-generation medicines. Participants include Harvard University, Massachusetts Institute of Technology, multiple medical institutes across the Boston area (Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham and Women’s Hospital, the Dana-Farber Cancer Institute, and Massachusetts General Hospital), the Commonwealth of Massachusetss, and private companies.

Click here to read more about the center which is estimated to cost $50 million dollars and the public-private partnerships spearheading the effort.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to tballard@pyapc.com. Include the name and contact information (phone and email) for follow-up.